Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00192634
What this trial is testing

A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study

Who this might be right for
HIV Infections
Kirby Institute 357
Not applicableStudy completedNCT04645693
What this trial is testing

The Impact of Oral Health in HIV Patients on Antiretroviral Therapy

Who this might be right for
HIVPeriodontal DiseasesCaries+2 more
University of Pennsylvania 227
Post-approval studies (Phase 4)Study completedNCT01327547
What this trial is testing

Maraviroc In HIV Co-Infected Subjects With Hepatitis C And/Or Hepatitis B

Who this might be right for
HIV Coinfection
ViiV Healthcare 138
Testing effectiveness (Phase 2)Study completedNCT00796822
What this trial is testing

Evaluating the Effectiveness of Pentoxifylline at Improving Blood Vessel Function in HIV-infected People Not Receiving Antiretroviral Medications

Who this might be right for
HIVCardiovascular DiseasesAtherosclerosis
Indiana University 26
Not applicableStudy completedNCT04233242
What this trial is testing

Genotype-Informed Versus Empiric Management of VirEmia

Who this might be right for
HIV-1-infection
Swiss Tropical & Public Health Institute 286
Not applicableLooking for participantsNCT06904456
What this trial is testing

Advanced HIV Disease During the First Six Months on Antiretroviral Therapy in Zambia

Who this might be right for
Advanced HIV Disease
Boston University 11,800
Not applicableStudy completedNCT01006005
What this trial is testing

Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens

Who this might be right for
HIV InfectionsAdherence
University of California, San Francisco 51
Testing effectiveness (Phase 2)Study completedNCT01775475
What this trial is testing

Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma

Who this might be right for
AIDS-related Diffuse Large Cell LymphomaAIDS-related Diffuse Mixed Cell LymphomaAIDS-related Diffuse Small Cleaved Cell Lymphoma+6 more
AIDS Malignancy Consortium 7
Not applicableStudy completedNCT00991302
What this trial is testing

Durability of Adherence in Self-Management of HIV

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 172
Not applicableStudy completedNCT03081572
What this trial is testing

Platelet Function on Abacavir and Tenofovir

Who this might be right for
Cardiovascular DiseasesPlatelet Aggregation, SpontaneousHIV/AIDS
University of California, Los Angeles 24
Testing effectiveness (Phase 2)Study completedNCT00110305
What this trial is testing

TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

Who this might be right for
Human Immunodeficiency Virus Type 1
Tibotec Pharmaceuticals, Ireland 368
Not applicableStudy completedNCT01369056
What this trial is testing

HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence

Who this might be right for
Acute HIV InfectionAcquired Immunodeficiency SyndromeMedication Adherence
University of Tartu 150
Post-approval studies (Phase 4)Ended earlyNCT00355251
What this trial is testing

Influence of Atorvastatin on Viral Replication During Antiretroviral Treatment Interruption

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 5
Early research (Phase 1)Study completedNCT07042945
What this trial is testing

MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 15
Post-approval studies (Phase 4)Ended earlyNCT00632970
What this trial is testing

Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals

Who this might be right for
HIV Infections
George Washington University 6
Large-scale testing (Phase 3)Study completedNCT01252212
What this trial is testing

Adherence, Improvement Measure (AIM) System

Who this might be right for
Patient ComplianceAIDS
University of California, San Francisco 99
Post-approval studies (Phase 4)Study completedNCT00885664
What this trial is testing

Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

Who this might be right for
HIV Infections
University of Cincinnati 60
Large-scale testing (Phase 3)Study completedNCT06403787
What this trial is testing

Effect of Aerobic Training and Ginkgo Biloba on Lipids Levels in HIV-positive Patients Undergoing Antiretroviral Treatment

Who this might be right for
Human Immunodeficiency Virus
University of Guadalajara 28
Not applicableLooking for participantsNCT06886971
What this trial is testing

Strategies to AchieVe Viral Suppression for Youth With HIV

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
Johns Hopkins University 288
Large-scale testing (Phase 3)Study completedNCT02537236
What this trial is testing

Omega-3 Supplementation in HIV Patients With Therapeutic Lifestyle Change Diet.

Who this might be right for
Human Immunodeficiency Virus
Instituto Mexicano del Seguro Social 200
Next Page